Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 922.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 875.0 | 67 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 781.5 | 66 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 810.0 | 60 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | VEGF | 727.5 | 66 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | VEGF | 1362.5 | 70 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 1318.0 | 51 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 907.5 | 62 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 1351.0 | 63 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 1523.5 | 60 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | VEGF | 1269.0 | 61 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | VEGF | 1350.5 | 46 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1273.0 | 57 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1404.0 | 59 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 859.5 | 74 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1391.5 | 54 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1276.5 | 60 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 767.0 | 51 | |
RA2159 | PI103 | 0.1 | uM | 3 | VEGF | 851.0 | 53 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1862.0 | 82 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1350.5 | 62 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1297.0 | 56 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1730.0 | 56 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1194.0 | 35 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1855.0 | 58 |